Electronic Xoft^® Inter-society Brachytherapy Trial

Breast Surgeons and Radiation Oncologists across the country now have an opportunity to participate in a landmark, multi-center national Accelerated Partial Breast Irradiation (APBI) trial. The EXIBT study is the first of its kind to use an independent core lab to evaluate patients treated with the Xoft Axxent^® Electronic Brachytherapy System for:

•   Mammographic changes
•   Cosmesis

The purpose of the study is to better understand the long-term outcomes in women treated with this accessible, patient-friendly method of APBI. The Xoft Axxent System is FDA cleared for commercial use, so your participation in this study will help collect data to better assess skin and subcutaneous cosmetic outcomes, and further prove the safety and efficacy of APBI using electronic brachytherapy.

The Oversight Committee, made up of key thought leaders from three physician societies, will monitor study conduct. The American Brachytherapy Society (ABS), the American Society of Breast Surgeons (ASBrS), and the American College of Radiation Oncology (ACRO) are all represented and will oversee the conduct of this registry. The Oversight Committee members include the following (in alphabetical order):   

	Douglas Arthur, MD	ABS
	Peter Beitsch, MD	ASBrS (PI)
	Jeffrey Demanes, MD	ACRO
	Arve Gillette, MD	ACRO
	Michael Kinney, MD	ASBrS
	Henry Kuerer, MD	ASBrS
	Helen Pass, MD	ASBrS
	Rakesh Patel, MD	ABS (PI)
	Frank Vicini, MD	ABS
	David Wazer, MD	ABS & ACRO
	James Welsh, MD	ACRO
	Pat Whitworth, MD	ASBrS

EXIBT Clinical Trial PDF

For more information or to notify Xoft Clinical Affairs about your interest in possible participation in the EXIBT Clinical Study, please fill out the form below and click send.

First Name (*)	Please provide your first name.
Last Name (*)	Please provide your last name.
Institution	Invalid Input
City (*)	To better serve you please provide your city.
State (*)	Select a State...AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict Of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming Please provide your State.
Specialty	Select One...Academic ResearchAdministrationPhysicistRNRadiation OncologistSurgeonOther Specialty... Invalid Input
Opt in	I would like to receive email updates from Xoft Inc. Invalid Input
E-mail Address (*)	Please provide your email address.
Phone Number	Invalid Input
How did you hear about the study?	Select One...ColleagueXoft Sales RepE-BlastRead about it in a trade publicationAt one of the following professional meetings:Other... Invalid Input
Or at one of the following professional meetings	ASTRO AAPM ACRO ASBS ABS ACS Invalid Input
Other Way Heard	Invalid Input
Please match the test image	Please match the test image.